Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Clinical trial NCT00519532 · TERMINATED

Trial details

NCT number: NCT00519532
Sponsor: UCB Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2007-07-01
Primary completion: 2009-05-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.